Public Alert No. 01/2025 – NAFDAC has Discontinued Registration of Multi-Dose Artemether /Lumefantrine Dry Powder for Oral Suspension
The National Agency for Food and Drug Administration and Control (NAFDAC) would like to inform the public that it has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. This decision was made due to the instability of the reconstituted formulations, which can lead to a loss of efficacy over time. This […]
